Posts tagged pmprb
BIOQUÉBEC, MONTRÉAL INVIVO AND SHERBROOKE INNOPOLE JOIN THEIR VOICES IN A LETTER ADDRESSED TO THE PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)
BIOQUÉBEC, MONTRÉAL INVIVO AND SHERBROOKE INNOPOLE JOIN THEIR VOICES IN A LETTER ADDRESSED TO THE PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)

On December 10th, 2021, BIOQuébec and other players in the life sciences industry in Quebec sent several federal elected officials their serious concerns regarding the coming into force of the PMPRB reform. As leading representatives of the Quebec life sciences sector who actively and strategically contribute to the country's economy, they asked that the implementation of the PMPRB reform be suspended. A year later, on December 5th, 2022, new developments compel Montréal InVivo, Sherbrooke Innopole and BIOQuébec to reiterate this request. A new request for the postponement of the coming into force of new guidelines has therefore been formulated as part of the PMPRB's consultation process.

Read More
Letter of opinionsGuest UserBIOOQuébecBIOQuébec, Life Sciences, healthcare, pmprb
PMPRB Revised Draft Guidelines: Ambiguity could further reduce availability of new medicines for Canadians
PMPRB Revised Draft Guidelines: Ambiguity could further reduce availability of new medicines for Canadians

Innovative Medicines Canada’s (IMC) initial interpretation of the Patented Medicine Prices Review Board’s (PMPRB) revised draft Guidelines is that they will further reduce the availability of new medicines in Canada by exacerbating an already unpredictable regulatory environment.

Read More
NewsGuest UserBIOOQuébecbiotechnology, drone technology, pmprb, Innovative Medicine Canada